SLNO — Soleno Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Soleno Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20.7	49.2	21.3	14.6	170
Net Total Receivables	0	—	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	21.1	50.2	22.4	15.6	171
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.444	0.158	0.454	0.157	0.419
Net Intangible Assets
Other Long Term Assets
Total Assets	38.2	65	35.6	26.5	181
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.96	8.62	8.01	7.31	11.5
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23.2	19.4	17.8	16.1	23.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	14.9	45.5	17.8	10.3	158
Total Liabilities & Shareholders' Equity	38.2	65	35.6	26.5	181
Total Common Shares Outstanding